Conference

About

Conference

About

Ethan Nadelmann, JD, PhD

PSYCHOACTIVE Podcast

Speaker Bio

Described by Rolling Stone as "The Point Man" for drug policy reform efforts and “the real drug czar,” Ethan Nadelmann, JD, PhD is widely regarded as the outstanding proponent of drug policy reform in the United States and abroad. After teaching politics and public affairs at Princeton University (1987-1994), he founded and directed first The Lindesmith Center (1994-2000) and then the https://drugpolicy.org/ (2000-2017). He also co-founded the Open Society Institute’s International Harm Reduction Development program.  Ethan has published extensively and spoken publicly in roughly forty states and forty countries. His https://www.ted.com/talks/ethan_nadelmann_why_we_need_to_end_the_war_on_drugs/tra has over two million views.

Ethan and his colleagues were at the forefront of dozens of successful campaigns to legalize marijuana, reduce the incarceration of drug law offenders, advance harm reduction approaches to drug use and addiction, and otherwise promote alternatives to the war on drugs.

Ethan hosts the leading podcast about all things drugs: https://open.spotify.com/show/0pfK53IF7WhEWtntXAFQ4W?si=089e358f7d284368. And he has become increasingly engaged in the debate over tobacco harm reduction.

ICPR 2024 Abstract

Integrating the Psychedelic Renaissance and Broader Drug Policy Reform

The psychedelic renaissance is rarely viewed in tandem with the broader drug policy reform agenda and movement. Psychedelic exceptionalism is both understandable and unfortunate. Psychedelics have, like other psychoactive substances, been stigmatized and criminalized.  Science and personal experience both play powerful roles in transforming public and individual awareness of the value and dangers of all psychoactive substances. The world of illicit drug harm reduction has much to learn from developments with psychedelic medicine and policy. At the same time, participants in the psychedelic renaissance have an intellectual and moral obligation to refrain from popular misconceptions regarding other stigmatized substances.

© 2007-2024 ICPR by OPEN Foundation, Amsterdam, the Netherlands
© 2007-2024 ICPR by OPEN Foundation, Amsterdam, the Netherlands
© 2007-2024 ICPR by OPEN Foundation, Amsterdam, the Netherlands